文献速递牙周病

糖尿病牙周非手术治疗中辅助全身抗生素对HbA1c的影响:系统综述

Effects on HbA1c in diabetic patients of adjunctive use of systemic antibiotics in nonsurgical periodontal treatment: A systematic review.
PubMed 文献 · J Dent · 2017-08-04

该系统综述评估糖尿病牙周非手术治疗中辅助使用全身抗生素对比单纯非手术治疗对平均糖化血红蛋白(HbA1c)降低的影响。

要点

  • 辅助全身抗生素未显著改善糖尿病牙周非手术治疗患者的HbA1c。
  • SRP联合抗生素与单纯SRP的HbA1c平均降幅差异无统计学意义。
  • 处方全身抗生素前应权衡风险与获益。

核心结论

  • 在糖尿病患者的牙周非手术治疗中,辅助使用全身抗生素对HbA1c改善无统计学显著获益。

研究设计与样本

  • 系统综述与荟萃分析,检索6个电子数据库、临床试验注册库、会议摘要及4种主要牙科期刊,纳入随访至少3个月的对照临床试验。

主要发现

  • 荟萃分析显示SRP联合抗生素对平均HbA1c降低无显著优势,加权均数差为-0.11%(95%CI -0.35至0.13;6项研究),预测区间为-0.45至0.23。
  • 亚抗菌剂量多西环素辅助使用对HbA1c平均降低也无显著优势,加权均数差为-0.19%(95%CI -1.04至0.67;2项研究)。

临床怎么用

  • 临床医生在牙周病治疗中为糖尿病患者处方全身抗生素前,应权衡其风险与获益。
  • 不应期望通过辅助全身抗生素来额外改善糖尿病患者的HbA1c控制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the effects of adjunctive use of systemic antibiotics in nonsurgical periodontal treatment compared to nonsurgical periodontal treatment alone, on mean glycated hemoglobin (HbA1c) reductions in patients with diabetes. DATA: Two independent reviewers screened six electronic databases, registers of clinical trials, meeting abstracts and four major dental journals for controlled clinical trials with at least 3-month follow-up. SOURCES: After duplicates removal, electronic and hand searches yielded 2136 records; 32 full-text articles were independently read by two reviewers. To evaluate the additional effect of antibiotic usage, pooled weighted mean differences and 95% confidence intervals were calculated using fixed and random effects models. STUDY SELECTION: Twelve studies met the inclusion criteria, nine of which provided data that allowed their inclusion in meta-analyses. The meta-analyses showed no significant effect favouring scaling and root planing (SRP) plus antibiotic for reductions in mean HbA1c (-0.11% [-0.35, 0.13]; 6 studies), and an estimated prediction interval varying from -0.45 to 0.23. There was also no significant effect favouring the adjunctive usage of sub-antimicrobial doxycycline in HbA1c mean reduction (-0.19% [-1.04, 0.67]; 2 studies). CONCLUSION: Adjunctive use of systemic antibiotic provides no statistically significant benefit in terms of HbA1c improvement in periodontal treatment of patients with diabetes. CLINICAL SIGNIFICANCE: Adjunctive use of systemic antibiotics associated with nonsurgical periodontal treatment provides no additional benefit in terms of HbA1c of diabetic patients. Clinicians should weigh the trade-off between risks and benefits provided by the use of systemic antibiotics before prescribing them for periodontal disease treatment.

来源:J Dent,查看原文。版权归原作者所有。

引用

  1. Lira Junior R, Santos CMM, Oliveira BH, et al. Effects on HbA1c in diabetic patients of adjunctive use of systemic antibiotics in nonsurgical periodontal treatment: A systematic review. J Dent. 2017. PMID: 28827017. doi:10.1016/j.jdent.2017.08.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。